Stay updated with breaking news from Science 37. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Science 37 Holdings, Inc. (NASDAQ:SNCE – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,470,000 shares, a growth of 48.8% from the February 28th total of 1,660,000 shares. Based on an average daily trading volume, of 892,200 […]
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced...
Science 37 (NASDAQ:SNCE – Get Rating) is one of 41 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare Science 37 to related businesses based on the strength of its dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Valuation & Earnings This table […]
By following the patient, home-based data collection enables more clinical trials to adopt agile (hybrid) and fully decentralized approaches....
Science 37 (NASDAQ:SNCE – Get Rating) and SomaLogic (NASDAQ:SLGC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Profitability This table compares Science 37 and SomaLogic’s net margins, […]